Recombinant DNA Technology Market

Nuclear Medicine Equipment Market Size, Share and Forecast 2025-2033

Rohit Pujari's photo
Rohit Pujari
·

4 min read

IMARC Group’s report titled “Nuclear Medicine Equipment Market Report by Product (Single-Photon Emission Computed Tomography, Positron Emission Tomography, Planar Scintigraphy), Application (Neurology, Oncology, Cardiology, and Others), End User (Hospitals, Imaging Centers, Academic and Research Institutes, and Others), and Region 2025-2033”, The global nuclear medicine equipment market size reached USD 3.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033.

Factors Affecting the Growth of the Nuclear Medicine Industry:

  • Technological Advancements:

The nuclear medicine equipment market is growing fast thanks to new technology. For example, hybrid imaging systems that combine nuclear medicine with CT or MRI scans are making diagnoses more accurate and improving patient care. These systems help doctors pinpoint tumors and plan treatments better. Portable and compact nuclear medicine devices are also being developed, making it easier to use this technology in outpatient clinics and remote areas. As healthcare providers see the benefits of these advanced tools, demand is increasing, helping doctors detect diseases earlier and provide personalized treatments.

  • Rising Chronic Diseases:

Chronic diseases like cancer and heart problems are becoming more common, driving the need for better diagnostic tools. Nuclear medicine is essential for identifying and managing these conditions because it shows detailed information about body processes that other imaging methods can’t. With a growing focus on early detection and prevention, more healthcare providers are using nuclear medicine, increasing demand for this technology. Additionally, as the population ages and faces more health issues, the need for advanced nuclear medicine equipment continues to grow.

  • Regulations and Insurance Policies:

Changes in regulations and insurance policies are also shaping the nuclear medicine market. Governments and healthcare organizations recognize how nuclear medicine improves patient care and reduces long-term costs. As a result, insurance coverage for nuclear medicine procedures is improving, making them more accessible. At the same time, regulatory agencies are speeding up approval processes for new technologies, encouraging more innovation and competition. These changes are helping the market grow by making nuclear medicine equipment easier to develop and use.

Grab a sample PDF of this report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample

Leading Companies Operating in the Global Nuclear Medicine Equipment Industry:

  • Biodex Medical Systems Inc. (Mirion Technologies Inc.)

  • Cardinal Health Inc.

  • CMR Naviscan Corporation

  • DDD-Diagnostic A/S

  • Digirad Corporation

  • General Electric Company

  • Koninklijke Philips N.V.

  • Mediso Ltd.

  • Neusoft Corporation

  • Siemens AG

  • SurgicEye GmbH

  • Toshiba Corporation

Nuclear Medicine Equipment Market Report Segmentation:

Breakup By Product:

  • Single-Photon Emission Computed Tomography

    • Standalone

    • Hybrid

  • Positron Emission Tomography

    • Standalone

    • Hybrid

  • Planar Scintigraphy

Breakup By Application:

  • Neurology

  • Oncology

  • Cardiology

  • Others

Breakup By End User:

  • Hospitals

  • Imaging Centers

  • Academic and Research Institutes

  • Others

Regional Insights:

  • North America (United States, Canada)

  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Latin America (Brazil, Mexico, Others)

  • Middle East and Africa

Nuclear Medicine Equipment Market Trends:

In 2024, several trends are shaping the nuclear medicine equipment market. Artificial intelligence (AI) and machine learning are being added to imaging systems, helping doctors analyze images faster and more accurately. There’s also a growing focus on personalized medicine, where treatments are customized for each patient, and nuclear medicine plays a key role in this approach. Technology companies and healthcare providers are teaming up more often, driving innovation and expanding access to nuclear medicine. Overall, the market is evolving quickly to meet changing healthcare needs and take advantage of new technology.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145

Nuclear Medicine Equipment Market